icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Drugs Safety Labeling Updates

Scientific Name Trade Name Updated Section Month
Alglucosidase Alfa Myozyme 4.8 Undesirable effects Sep,2022
Dolutegravir Tivicay 4.4 Special Warnings and Special Precautions for Use Sep,2022
Oxcarbazepine Trileptal 4.2 Posology And Method Administration 6.6. Special precautions for disposal and other handling Sep,2022
Ertugliflozin, Sitagliptin Steglujan 4.5. Interactions with other medicinal products Oct,2022
Ertugliflozin, Metformin Hydrochloride Segluromet 4.5. Interactions with other medicinal products Oct,2022
Ertugliflozin Steglatro 4.5. Interactions with other medicinal products Oct,2022
Canagliflozin Invokana 4.5. Interactions with other medicinal products Oct,2022
Topiramate Topamax 4.4. Special warnings and precautions for use Oct,2022
Dolutegravir, Lamivudine Dovato 4.8. Undesirable effects Oct,2022
Lansoprazole Lanzor 4.4. Special warnings and precautions for use Oct,2022